PSG9 and neoplasm: Moreover, CRC patients with tumors > 5 cm showed higher serum PSG9 levels than those with tumors ≤ 5 cm, and it was found that PSG9 had the potential to promote tumor cell proliferation (Figure 1B, Supplementary Table S1).